References
- Kruger L. Structural aspects of trigeminal neuralgia: A summary of current findings and concepts. J Neurosurg 1967; 26: 109–90
- List C F, Williams J R. Pathogenesis of trigeminal neuralgia—A review. Arch Neurol Psychiat 1957; 77: 36–43
- Brunelli G, Milanesi S, Bartolaminelli P, et al. Vertebral fractures—experimental grafts in spinal cord lesions. (Preliminary report.). Hal J Orthop Traumalol 1983; 9((Suppl.))53–6
- Wrathall J R, Kapoor V, Kao C C. Observation of cultural peripheral non-neuronal cells implanted into the transected spinal cord. Acta Neuropathol (Bed) 1984; 64: 203–12
- Viale G L. Giant cell tumours of the sellar region. Acta Neurochir (Wien) 1977; 38: 259–68
- Wolfe J T, III, et al. Giant-cell tumor of the sphenoid bone. Review of 10 cases. J Neurosurg 1983; 59: 322–7
- Tartarini E, et al. Giant cell tumor of the sphenoid bone (Osteoclastoma). Zbl Neurochir 1955; 6: 323–9
- Perria L, et al. Riesenzelltumore (Osteoklastome) der Sellagegend. Acta Neurochir (Wien) 1968; 19: 183–97
- Nascimento A G, et al. Primary malignant giant cell tumor of bone. A study of eight cases and review of the lierature. Cancer 1979; 44: 1393–402
- Fabiani A, et al. Benign and malignant cranio-spinal giant cell tumours. Report of four cases. Acta Neurochir (Wien) 1982; 64: 133–50
- Pigott T J, Lowe J S, Palmer J. Statistical modelling in analysis of prognosis in glioblastoma multiforme: a study of clinical variables and Ki-67 index. Br J Neurosurg 1991; 5: 61–6
- Hoshino T. Proliferative potential of human brain tumours. Abstracts of an International Symposium on Advances in Neuro-oncology, San RemoItaly, September, 1990, 3
- Baisch H, Gerdes J. Simultaneous staining of exponentially growing verus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tiss Kin 1987; 20: 387–91
- van Dierendonck J H, Keijezer R, van der Velde C JH, Cornelisse C J. Nuclear distribution of the Ki-67 antigen during the cell cycle: Comparison with growth fraction in human breast cancer cells. Can Res 1989; 49: 2999–3006
- Verhuijen R, Kuijpers H JH, van Driel R. Ki-67 detects a nuclear matrix-associated proliferation related antigen II: Localisation in mitotic cells and association with chromosomes. J Cell Sci 1989; 92: 531–40
- Waseem N H, Lane D P. Monoclonal antibody analysis of the proliferating nuclear antigen (PCNA): Structural conservation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121–9
- Hall P A, Levison D A, Woods A L, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Path 1990; 162: 285–94
- Wang E. A 57,000-mol-wt protein uniquely present in non-proliferating cells and senescent human fibroblasts. J Cell Biol 1985; 100: 545–51
- Schipper H N, Skalski V, Panasci L C, Wang E. Statin expression in the untreated and SarCNU-exposed human glioma cell line, SK-MG-1. Cane Chemother Pharm 1990; 26: 383–86
- Begg A C, McNally N J, Schrieve D C, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–26
- Wilson G D, McNally N J, Dische S, et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cane 1988; 58: 423–31